<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04534348</url>
  </required_header>
  <id_info>
    <org_study_id>STERILE</org_study_id>
    <nct_id>NCT04534348</nct_id>
  </id_info>
  <brief_title>Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps</brief_title>
  <acronym>STERILE</acronym>
  <official_title>Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study on the reduction of catheter-related Infections by use of&#xD;
      self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of CLABSI</measure>
    <time_frame>12 Months</time_frame>
    <description>To assess the clinical efficacy of Curos in preventing CLABSI in a high-risk department (oncology and ICU)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">598</enrollment>
  <condition>CLABSI - Central Line Associated Bloodstream Infection</condition>
  <condition>Catheter-Related Blood Stream Infection</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>All central-line-associated blood stream infections (CLABSI) diagnosed during the year previous the implementation of 70% isopropyl alcohol-impregnated Curos catheter caps</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CUROS</arm_group_label>
    <description>All central-line-associated blood stream infections (CLABSI) diagnosed during the year after the implementation of 70% isopropyl alcohol-impregnated Curos catheter caps</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>70% isopropyl alcohol-impregnated catheter caps</intervention_name>
    <description>Implementation of 70% isopropyl alcohol-impregnated catheter caps in order to assess the number of CLABSI diagnosed during 1 Year</description>
    <arm_group_label>CUROS</arm_group_label>
    <other_name>CUROS (3M)</other_name>
    <other_name>self disinfecting catheter caps</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients treated in the hemato-oncological department at the University Clinic in&#xD;
        Cologne, Germany, receiving a central-line catheter during one year previous to the&#xD;
        implementation of alcohol-impregnated catheter caps as well as all patients receiving a&#xD;
        central-line catheter during the 12 months following the implementation of CUROS were&#xD;
        included in this study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  every patient in the hemato-oncological department who received at least one CVC was&#xD;
             included in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Cologne</name>
      <address>
        <city>Cologne</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>August 26, 2020</last_update_submitted>
  <last_update_submitted_qc>August 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Maria J.G.T. Vehreschild</investigator_full_name>
    <investigator_title>Prof. Dr. med</investigator_title>
  </responsible_party>
  <keyword>CLABSI</keyword>
  <keyword>CRBSI</keyword>
  <keyword>Blood Stream Infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

